Activation of platelets by sera containing igg1 heparin-dependent antibodies: an explanation for the predominance of the Fcγrlla “low responder” (his131) gene in patients with heparin-induced thrombocytopenia

This publication has 25 references indexed in Scilit:

• A diagnostic test for heparin‐induced thrombocytopenia: detection of platelet microparticles using flow cytometry
  British Journal of Haematology, 1996
• Comparison of PF4/Heparin ELISA Assay With the¹⁴C-Serotonin Release Assay in the Diagnosis of Heparin-induced Thrombocytopenia
  American Journal of Clinical Pathology, 1995
• Single amino acid mutation of FCγ receptor is associated with the development of heparin‐induced thrombocytopenia
  British Journal of Haematology, 1995
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
  New England Journal of Medicine, 1995
• Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells.
  Journal of Clinical Investigation, 1994
• Differential expression of Fcγ RIIA, Fcγ RIIB and Fcγ RIIC in hematopoietic cells: Analysis of transcripts
  Molecular Immunology, 1993
• A single amino acid distinguishes the high‐responder from the low‐responder form of Fc receptor II on human monocytes
  European Journal of Immunology, 1991
• Molecular basis for a polymorphism of human Fc gamma receptor II (CD32).
  The Journal of Experimental Medicine, 1990
• Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with platelets
  British Journal of Haematology, 1989
• Polymorphism in mitogenic effect of IgG1 monoclonal antibodies against T3 antigen on human T cells
  Nature, 1983